Oral vs IV corticosteroids for in-hospital treatment of COPD exacerbations

Chest

Volumn 134, Issue 2, 2008, Pages 470-

  Nicholas, S Scott ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Eisenstadt Allergy and Asthma LLP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PREDNISOLONE;

ASTHMA; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DRUG DOSE COMPARISON; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; LETTER; OUTPATIENT; PRIORITY JOURNAL; SINGLE DRUG DOSE; STEROID THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 49449112603     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.08-0289     Document Type: Letter

References (3)

1. de Jong YP, Uil SM, Grotjohan HP, et al. Oral or intravenous prednisolone in the treatment of COPD exacerbation: a randomized controlled double blind study. Chest 2007; 132: 1741-1747
2. Tashkin DP. Oral vs IV corticosteroids for in-hospital treatment of COPD exacerbations [editorial]. Chest 2007; 132:1728-1729
3. Niewoehner DE, Erbland MC, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1999; 340:1941-1947